These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16720366)

  • 41. Inhibition of Moloney murine leukaemia virus by a retroviral vector, LNL6, carrying ribozymes targeted to the 5' non-coding sequence.
    Lowenstein P; Symonds G
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2587-90. PubMed ID: 9349479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.
    Veres G; Junker U; Baker J; Barske C; Kalfoglou C; Ilves H; Escaich S; Kaneshima H; Böhnlein E
    J Virol; 1998 Mar; 72(3):1894-901. PubMed ID: 9499041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA.
    Qureshi A; Zheng R; Parlett T; Shi X; Balaraman P; Cheloufi S; Murphy B; Guntermann C; Eagles P
    Biochem J; 2006 Mar; 394(Pt 2):511-8. PubMed ID: 16293105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and characterization of a highly efficient anti-HIV pol hammerhead ribozyme.
    Müller-Kuller T; Capalbo G; Klebba C; Engels JW; Klein SA
    Oligonucleotides; 2009 Sep; 19(3):265-72. PubMed ID: 19732019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance.
    Lu X; Yu Q; Binder GK; Chen Z; Slepushkina T; Rossi J; Dropulic B
    J Virol; 2004 Jul; 78(13):7079-88. PubMed ID: 15194784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A helix 1-extended hairpin ribozyme exhibits altered cleavage behavior in vitro.
    Moosbauer J; Tabler M
    Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):79-87. PubMed ID: 9149843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection.
    Biasolo MA; Radaelli A; Del Pup L; Franchin E; De Giuli-Morghen C; Palu G
    J Virol; 1996 Apr; 70(4):2154-61. PubMed ID: 8642637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
    Phylactou LA; Tsipouras P; Kilpatrick MW
    Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
    Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E
    Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of human immunodeficiency virus type 1 by packageable, multigenic antisense RNA.
    Shahabuddin M; Khan AS
    Antisense Nucleic Acid Drug Dev; 2000 Jun; 10(3):141-51. PubMed ID: 10905551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
    Bai J; Banda N; Lee NS; Rossi J; Akkina R
    Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extension of helix II of an HIV-1-directed hammerhead ribozyme with long antisense flanks does not alter kinetic parameters in vitro but causes loss of the inhibitory potential in living cells.
    Homann M; Tabler M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3951-7. PubMed ID: 7524030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes.
    VandenDriessche T; Chuah MK; Chiang L; Chang HK; Ensoli B; Morgan RA
    J Virol; 1995 Jul; 69(7):4045-52. PubMed ID: 7769662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
    Sioud M
    Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
    Nash KL; Alexander GJ; Lever AM
    J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Additive and antagonist effects of therapeutic gene combinations for suppression of HIV-1 infection.
    Gennari F; Biasolo MA; Cancellotti E; Radaelli A; De Giuli Morghen C; Bozzoni I; Cereda PM; Mengoli C; Palù G; Parolin C
    Antiviral Res; 2002 Jul; 55(1):77-90. PubMed ID: 12076753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A ribozyme gene and an antisense gene are equally effective in conferring resistance to tobacco mosaic virus on transgenic tobacco.
    de Feyter R; Young M; Schroeder K; Dennis ES; Gerlach W
    Mol Gen Genet; 1996 Feb; 250(3):329-38. PubMed ID: 8602148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs.
    Sun LQ; Pyati J; Smythe J; Wang L; Macpherson J; Gerlach W; Symonds G
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7272-6. PubMed ID: 7638180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells.
    Hübinger G; Schmid M; Linortner S; Manegold A; Bergmann L; Maurer U
    Exp Hematol; 2001 Oct; 29(10):1226-35. PubMed ID: 11602325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle.
    Chadwick DR; Lever AM
    Gene Ther; 2000 Aug; 7(16):1362-8. PubMed ID: 10981662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.